Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. Read more about Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. Read more about Prostate Cancer Susceptibility in Men of African Ancestry at 8q24.
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. Read more about A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer. Read more about Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer.
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Read more about Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.
Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. Read more about Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. Read more about Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. Read more about CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
Prediction of breast cancer risk based on profiling with common genetic variants. Read more about Prediction of breast cancer risk based on profiling with common genetic variants.
